期刊论文详细信息
Frontiers in Veterinary Science
Investigation of the impact of clonal hematopoiesis on severity and pathophysiology of COVID-19 in rhesus macaques
Veterinary Science
Anthony Cook1  Mark G. Lewis1  Ian N. Moore2  Cynthia E. Dunbar3  Byung-Chul Lee3  So Gun Hong3  Tae-Hoon Shin4  Yifan Zhou5  Daniel C. Douek6  John-Paul M. Todd6  Kathryn E. Foulds6  Barbara J. Flynn6  Matthew Gagne6  Robert A. Seder6  Mario Roederer6  Shayne F. Andrew6 
[1] Bioqual, Inc., Rockville, MD, United States;Division of Pathology, Yerkes National Primate Research Center, Emory University School of Medicine, Atlanta, GA, United States;Translational Stem Cell Biology Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD, United States;Translational Stem Cell Biology Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD, United States;Department of Laboratory Animal Medicine, College of Veterinary Medicine and Veterinary Medical Research Institute, Jeju National University, Jeju, Republic of Korea;Translational Stem Cell Biology Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD, United States;Haematological Cancer Genetics, Wellcome Trust Sanger Institute, Cambridge, United Kingdom;Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom;Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States;
关键词: clonal hematopoiesis;    COVID-19;    SARS-CoV-2;    rhesus macaque;    aging;    hyperinflammation;   
DOI  :  10.3389/fvets.2023.1182197
 received in 2023-03-08, accepted in 2023-06-12,  发布年份 2023
来源: Frontiers
PDF
【 摘 要 】

Clinical manifestations of COVID-19 vary widely, ranging from asymptomatic to severe respiratory failure with profound inflammation. Although risk factors for severe illness have been identified, definitive determinants remain elusive. Clonal hematopoiesis (CH), the expansion of hematopoietic stem and progenitor cells bearing acquired somatic mutations, is associated with advanced age and hyperinflammation. Given the similar age range and hyperinflammatory phenotype between frequent CH and severe COVID-19, CH could impact the risk of severe COVID-19. Human cohort studies have attempted to prove this relationship, but conclusions are conflicting. Rhesus macaques (RMs) are being utilized to test vaccines and therapeutics for COVID-19. However, RMs, even other species, have not yet been reported to develop late inflammatory COVID-19 disease. Here, RMs with either spontaneous DNMT3A or engineered TET2 CH along with similarly transplanted and conditioned controls were infected with SARS-CoV-2 and monitored until 12 days post-inoculation (dpi). Although no significant differences in clinical symptoms and blood counts were noted, an aged animal with natural DNMT3A CH died on 10 dpi. CH macaques showed evidence of sustained local inflammatory responses compared to controls. Interestingly, viral loads in respiratory tracts were higher at every timepoint in the CH group. Lung sections from euthanasia showed evidence of mild inflammation in all animals, while viral antigen was more frequently detected in the lung tissues of CH macaques even at the time of autopsy. Despite the lack of striking inflammation and serious illness, our findings suggest potential pathophysiological differences in RMs with or without CH upon SARS-CoV-2 infection.

【 授权许可】

Unknown   
Copyright © 2023 Shin, Zhou, Lee, Hong, Andrew, Flynn, Gagne, Todd, Moore, Cook, Lewis, Foulds, Seder, Douek, Roederer and Dunbar.

【 预 览 】
附件列表
Files Size Format View
RO202310101778932ZK.pdf 1776KB PDF download
  文献评价指标  
  下载次数:30次 浏览次数:0次